Enliven Therapeutics (ELVN) Insider Trading & Ownership $17.77 -0.20 (-1.11%) Closing price 04:00 PM EasternExtended Trading$17.73 -0.04 (-0.23%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enliven Therapeutics (NASDAQ:ELVN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$32.81 M Get ELVN Insider Trade Alerts Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ELVN Insider Buying and Selling by Quarter Enliven Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/21/2025Joseph P LyssikatosInsiderSell5,000$16.07$80,350.00 4/17/2025Samuel KintzCEOSell5,000$16.42$82,100.00 4/7/2025Anish PatelCOOSell6,667$18.04$120,272.68 3/27/2025Benjamin HohlCFOSell3,250$21.33$69,322.50 3/24/2025Benjamin HohlCFOSell1,000$22.50$22,500.00 3/19/2025Joseph P LyssikatosInsiderSell12,500$20.61$257,625.00 3/17/2025Samuel KintzCEOSell12,500$20.83$260,375.00 3/7/2025Anish PatelCOOSell6,667$21.44$142,940.48 2/27/2025Benjamin HohlCFOSell3,250$20.41$66,332.50 2/7/2025Anish PatelCOOSell6,667$21.93$146,207.31 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/5/2025Benjamin HohlCFOSell1,000$22.52$22,520.00 1/27/2025Benjamin HohlCFOSell3,250$21.59$70,167.50 1/7/2025Anish PatelCOOSell21,700$24.18$524,706.00 1/3/2025Benjamin HohlCFOSell1,000$25.04$25,040.00 12/30/2024Benjamin HohlCFOSell900$22.51$20,259.00 12/27/2024Benjamin HohlCFOSell3,350$22.15$74,202.50 11/27/2024Benjamin HohlCFOSell5,250$24.89$130,672.50 10/28/2024Benjamin HohlCFOSell6,250$28.56$178,500.00 10/18/2024Anish PatelCOOSell716$30.00$21,480.00 10/18/2024Benjamin HohlCFOSell814$30.00$24,420.00 10/18/2024Joseph P LyssikatosInsiderSell847$30.00$25,410.00 10/18/2024Richard A HeymanDirectorSell817$30.00$24,510.00 10/18/2024Samuel KintzCEOSell924$30.00$27,720.00 10/15/2024Richard A HeymanDirectorSell1,270$27.67$35,140.90 10/9/2024Joseph P LyssikatosInsiderSell37,878$28.16$1,066,644.48 10/9/2024Samuel KintzCEOSell16,710$28.15$470,386.50 10/8/2024Rahul D BallalDirectorSell10,420$28.17$293,531.40 10/7/2024Benjamin HohlCFOSell1,270$27.51$34,937.70 10/7/2024Joseph P LyssikatosInsiderSell2,707$27.61$74,740.27 10/7/2024Samuel KintzCEOSell2,730$27.50$75,075.00 10/4/2024Benjamin HohlCFOSell10,218$27.51$281,097.18 10/4/2024Joseph P LyssikatosInsiderSell7,522$27.51$206,930.22 10/4/2024Richard A HeymanDirectorSell2,825$27.51$77,715.75 10/4/2024Samuel KintzCEOSell12,206$27.51$335,787.06 10/1/2024Joseph P LyssikatosInsiderSell527$27.54$14,513.58 10/1/2024Richard A HeymanDirectorSell518$27.54$14,265.72 10/1/2024Samuel KintzCEOSell526$27.54$14,486.04 9/30/2024Benjamin HohlCFOSell2,000$25.33$50,660.00 9/27/2024Benjamin HohlCFOSell4,250$24.27$103,147.50 8/29/2024Joseph P LyssikatosInsiderSell12,000$22.49$269,880.00 Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.8/27/2024Benjamin HohlCFOSell4,250$22.54$95,795.00 8/26/2024Samuel KintzCEOSell12,000$22.89$274,680.00 8/15/2024Richard A HeymanDirectorSell1,270$23.25$29,527.50 7/31/2024Benjamin HohlCFOSell991$27.53$27,282.23 7/31/2024Joseph P LyssikatosInsiderSell3,099$27.56$85,408.44 7/31/2024Richard A HeymanDirectorSell1,702$27.51$46,822.02 7/31/2024Samuel KintzCEOSell2,270$27.56$62,561.20 7/29/2024Benjamin HohlCFOSell5,250$26.68$140,070.00 7/29/2024Joseph P LyssikatosInsiderSell12,000$26.70$320,400.00 7/25/2024Samuel KintzCEOSell12,000$24.92$299,040.00 7/15/2024Anish PatelCOOSell30,978$25.05$775,998.90 7/15/2024Richard A HeymanDirectorSell1,270$24.80$31,496.00 7/12/2024Anish PatelCOOSell17,475$25.07$438,098.25 7/12/2024Benjamin HohlCFOSell3,000$25.07$75,210.00 6/27/2024Benjamin HohlCFOSell4,250$22.57$95,922.50 6/25/2024Samuel KintzCEOSell12,000$21.66$259,920.00 6/6/2024Anish PatelCOOSell1,133$20.06$22,727.98 5/28/2024Benjamin HohlCFOSell4,250$23.18$98,515.00 5/28/2024Samuel KintzCEOSell12,000$23.18$278,160.00 5/16/2024Rishi GuptaDirectorSell1,033,300$22.14$22,877,262.00 5/14/2024Anish PatelCOOSell1,107$25.00$27,675.00 5/9/2024Anish PatelCOOSell260$25.06$6,515.60 5/6/2024Anish PatelCOOSell4,875$22.72$110,760.00 5/3/2024Benjamin HohlCFOSell1,000$22.50$22,500.00 4/29/2024Benjamin HohlCFOSell3,250$16.97$55,152.50 4/29/2024Joseph P. LyssikatosinsiderSell12,000$17.92$215,040.00 4/25/2024Samuel KintzCEOSell12,000$16.89$202,680.00 (Data available from 1/1/2013 forward) ELVN Insider Trading Activity - Frequently Asked Questions Who is on Enliven Therapeutics's Insider Roster? The list of insiders at Enliven Therapeutics includes 5Am Partners Vi, Llc, Anish Patel, Benjamin Hohl, Joseph P Lyssikatos, Rahul D Ballal, Richard A Heyman, Rishi Gupta, and Samuel Kintz. Learn more on insiders at ELVN. What percentage of Enliven Therapeutics stock is owned by insiders? 29.20% of Enliven Therapeutics stock is owned by insiders. Learn more on ELVN's insider holdings. Which Enliven Therapeutics insiders have been selling company stock? The following insiders have sold ELVN shares in the last 24 months: 5Am Partners Vi, Llc ($17,502,500.00), Anish Patel ($3,271,052.71), Benjamin Hohl ($2,454,014.54), Joseph P Lyssikatos ($2,401,901.99), Rahul D Ballal ($1,700,961.11), Richard A Heyman ($349,650.29), Rishi Gupta ($22,877,262.00), and Samuel Kintz ($4,890,872.78). How much insider selling is happening at Enliven Therapeutics? Insiders have sold a total of 2,936,643 Enliven Therapeutics shares in the last 24 months for a total of $57,302,977.10 sold. Enliven Therapeutics Key ExecutivesMr. Samuel S. Kintz M.B.A. (Age 38)Co-Founder, CEO, Secretary & Director Compensation: $866.41kDr. Joseph P. Lyssikatos Ph.D. (Age 59)Co-Founder & Chief Scientific Officer Compensation: $632.67kDr. Helen Louise Collins M.D. (Age 61)Chief Medical Officer Compensation: $686.19kMr. Anish Patel Pharm.D. (Age 43)Co-Founder & COO Mr. Benjamin Hohl (Age 34)CFO & Head of Corporate Development Compensation: $488.5k10 recent tradesDr. Galya D. Blachman Esq. (Age 47)Ph.D., Chief Legal Officer & Head of Business Development More Insider Trading Tools from MarketBeat Related Companies Arcellx Insider Buying Ultragenyx Pharmaceutical Insider Buying Avidity Biosciences Insider Buying Akero Therapeutics Insider Buying Merus Insider Buying Organon & Co. Insider Buying SpringWorks Therapeutics Insider Buying Crinetics Pharmaceuticals Insider Buying Catalyst Pharmaceuticals Insider Buying Protagonist Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:ELVN) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELVN Stock Free ELVN Stock Alerts